// App-Quantinova.ai

: ADVERSE EVENTS AND THE RELAPSE RISK OF SYSTEMIC LUPUS ERYTHEMATOSUS DURING HYDROXYCHLOROQUINE TREATMENT

Researchers

Presenter

  • Kunihiro Ichinose

Principal Investigators

  • Akinari Mizokami

  • Toshiyuki Aramaki

  • Yukitaka Ueki

  • Mizuna Eguchi

  • Momoko Okamoto

  • Yushiro Endo

  • Sousuke Tsuji

  • Ayuko Takatani

  • Toshimasa Shimizu

  • Remi Sumiyoshi

  • Tomohiro Koga

  • Shin-Ya Kawashiri

  • Naoki Iwamoto

  • Takashi Igawa

  • Mami Tamai

  • Hideki Nakamura

  • Tomoki Origuchi

  • Atsushi Kawakami

Medical Centers

  • Nagasaki University Graduate School of Biomedical Sciences, Department of Immunology and Rheumatology, Division of Advanced Preventive Medical Sciences, Nagasaki, Japan

  • JCHO Isahaya General Hospital Department of Rheumatology, Isahaya, Japan

  • Sasebo Chuo Hospital Rheumatic and Collagen Disease Center, Sasebo, Japan

  • Nagasaki University Graduate School of Biomedical Sciences, Department of Rehabilitation Sciences, Nagasaki, Japan

Locations

  • Japan

Companies

  • N/A

Study Components

Therapeutic Area

  • Autoimmune (AI)

Disease

  • Lupus

Biomarkers

  • N/A

Drug/Treatment

  • Hydroxychloroquine

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved